Soluble HLA class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy

Human Immunology

Volumn 50, Issue 2, 1996, Pages 135-139

  Tambutti, Monica L ^a   Ferraris, Jorge R ^a   Redal, Maria A ^a   Ramirez, Jose A ^a   Prigoshin, Norma ^a,b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIGEN CLASS 1; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL;

EID: 0030271386     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00125-5     Document Type: Article

References (15)

1. 1. Charlton R, Zmijewski C: Soluble HL-A7 antigen: localization in the β-lipoprotein fraction of human serum. Science 70:636, 1970.
2. 2. Van Rood J, Van Leeuwen A, Van Santen M: Anti HL-A2 inhibitor in normal human serum. Nature 226:366, 1970.
3. 3. Ferrone S, Yamamura M, Grosse-Wilde H, Pouletty P: Summary of the serum-soluble HLA class I antigen component. In Kimiyoshi Tsuji, Miki Aizawa, and Takehico Sasazuki (eds): Proceeding of the 11th International Histocompatibility Workshop and Conference 1057, 1991.
4. 4. Brieva JA, Villar LM, Leoro G, Alvarez-Cermeño JC, Roldan E, Gonzalez-Porqué P: Soluble HLA class I antigens secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol 82:390, 1990.
5. 5. Puppo F, Pellicci R, Brenci S, et al.: HLA class I soluble antigen serum levels in liver transplantation. Hum Immunol 40:166, 1994.
6. 6. Puppo F, Scudeletti M, Indiveri F, Ferrone S: Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 16:124, 1995.
7. 7. Doxiadis I, Westhoff U, Grosse-Wilde H: Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59:449, 1989.
8. 8. Kao KJ, Scornik JC, Riley WJ, McQueen CF: Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 21:115, 1988.
9. 9. Schroeder T, Pouletty P, Shimizu R, et al.: Soluble class I HLA antigens in serum following renal transplantation. 2nd international workshop on Soluble HLA antigens. Hum Immunol 37:130, 1993.
10. 10. Lynn D, De Vito Haynes, Ewa Jankowska-Gan, et al.: Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40:191, 1994.
11. 11. Pouletty C, Mercier I, Hult M, et al.: Soluble HLA class I typing ELISA using monoclonal antibodies. 2nd international workshop on Soluble HLA Antigens. Hum Immunol 37:128, 1993.
12. 12. Fotino M: DTT modification of the lymphocytotoxicity assay. In AA, Z, GA, T (eds): American Society for Histocompatibility and Immuno-genetics. Laboratory Manual, New York, 321, 1990.
13. 13. Johnson AH, Rossen RD, Butler WT: Detection of alloantibodies using a sensitive antigammaglobulin microcytotoxicity test: identification of low levels of preformed antibodies in accelerated allograft rejection. Tissue Antigens 2:215, 1972.
14. 14. Zavazava N, Böttcher H, Müller-Ruchholtz W: Soluble class I antigens (sHLA) and anti-HLA antibodies in a pannel of cardiac and renal graft patients. Tissue Antigens 42:20, 1993.
15. 15. Ra A: NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15:274, 1994.